A questionnaire survey on the management of Graves' orbitopathy in China: A comparison with Europe and Latin-America
Objective: Management of Graves' orbitopathy (GO) continues to be a challenge to clinical endocrinologists. In the last few years, surveys on GO management have succeeded in elucidating trends in Europe and Latin America. To determine how endocrinologists in China assess and treat patients with...
Guardado en:
Autores principales: | Shu-Hang Xu, Xing-Jia Li, Guo-Fang Chen, Quan-Xi Zheng, Yu Yang, Yong-Xin Hu, Kun Wang, Chao Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fad291c7a5e94838b8fa034e8d90b8f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Orbital Signaling in Graves’ Orbitopathy
por: Mohd Shazli Draman, et al.
Publicado: (2021) -
Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
por: Sun Young Jang, et al.
Publicado: (2021) -
Endoscopic Orbital Decompression for Graves’ Orbitopathy – A Vietnam Study
por: Pham TMH, et al.
Publicado: (2021) -
Reasons for revision surgery after orbital decompression for Graves’ orbitopathy
por: Stefano Sellari-Franceschini, et al.
Publicado: (2008) -
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
por: Tsirouki T, et al.
Publicado: (2016)